Indivior Pharmaceuticals Inc. (INDV) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
Indivior Pharmaceuticals Inc. and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. Kiniksa Pharmaceuticals International, plc is the larger, with a market value of $6.2B against $4.0B — 1.6× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 11.2× against 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 13.5%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 9.59%) and the higher return on invested capital (460.5% vs 48.9%). Across the 18 metrics below, Indivior Pharmaceuticals Inc. leads on 11 and Kiniksa Pharmaceuticals International, plc on 7.
Valuation
Profitability
| Metric | INDV | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 81.97% | 89.82% | 53.94% |
| Operating margin | 31.56% | 11.92% | 0.00% |
| Net margin | 26.75% | 9.59% | 0.00% |
| Free cash flow margin | (8.34%) | 21.74% | 0.00% |
| Return on equity | (153.12%) | 14.04% | (0.40%) |
| Return on assets | 26.52% | 10.36% | (3.32%) |
| Return on invested capital | 460.53% | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack